For: | Zhang MH, Setchell KD, Zhao J, Gong JY, Lu Y, Wang JS. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes. World J Gastroenterol 2019; 25(7): 859-869 [PMID: 30809085 DOI: 10.3748/wjg.v25.i7.859] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i7/859.htm |
Number | Citing Articles |
1 |
Jing Zhao, Yi-Ling Qiu, Li Wang, Zhong-Die Li, Xin-Bao Xie, Yi Lu, Kenneth D.R. Setchell, Ye Cheng, Qing-He Xing, Jian-She Wang. Recurrent AKR1D1 c.580-13T>A Variant. The Journal of Molecular Diagnostics 2023; 25(4): 227 doi: 10.1016/j.jmoldx.2023.01.004
|
2 |
Akihiko Kimura, Tatsuki Mizuochi, Hajime Takei, Akira Ohtake, Jun Mori, Kunihiro Shinoda, Takuji Hashimoto, Mureo Kasahara, Takao Togawa, Tsuyoshi Murai, Takashi Iida, Hiroshi Nittono. Bile Acid Synthesis Disorders in Japan: Long-Term Outcome and Chenodeoxycholic Acid Treatment. Digestive Diseases and Sciences 2021; 66(11): 3885 doi: 10.1007/s10620-020-06722-4
|
3 |
Antoine Gardin, Mathias Ruiz, Jan Beime, Mara Cananzi, Margarete Rathert, Barbara Rohmer, Enke Grabhorn, Marion Almes, Veena Logarajah, Luis Peña-Quintana, Thomas Casswall, Amaria Darmellah-Remil, Ana Reyes-Domínguez, Emna Barkaoui, Loreto Hierro, Carolina Baquero-Montoya, Ulrich Baumann, Björn Fischler, Emmanuel Gonzales, Anne Davit-Spraul, Sophie Laplanche, Emmanuel Jacquemin. ∆4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid. Orphanet Journal of Rare Diseases 2023; 18(1) doi: 10.1186/s13023-023-02984-z
|
4 |
Frans Stellaard, Dieter Lütjohann. Dynamics of the enterohepatic circulation of bile acids in healthy humans. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 321(1): G55 doi: 10.1152/ajpgi.00476.2020
|
5 |
Anh-Hoa Nguyen Pham, Kim-Oanh Bui Thi, Mai-Huong Nguyen Thi, Diem-Ngoc Ngo, Nakayuki Naritaka, Hiroshi Nittono, Hisamitsu Hayashi, Trang Thi Dao, Kim-Huong Thi Nguyen, Hoai-Nghia Nguyen, Hoa Giang, Hung-Sang Tang, Tat-Thanh Nguyen, Dinh-Kiet Truong, Minh-Dien Tran. Clinical and genetic features of congenital bile acid synthesis defect with a novel mutation in AKR1D1 gene sequencing. Medicine 2022; 101(25): e29476 doi: 10.1097/MD.0000000000029476
|
6 |
Kenneth D.R. Setchell, James E. Heubi. Liver Disease in Children. 2021; : 593 doi: 10.1017/9781108918978.033
|
7 |
|
8 |
Rune Rose Tronstad, Siren Berland, Erling Tjora, Khadija El Jellas, Ingvild Aukrust, Kurt Kristensen, Dag Tveitnes, Anders Molven, Hanns-Ulrich Marschall, Anuradha Rao, Paul A. Dawson. Fat Malabsorption and Ursodeoxycholic Acid Treatment in Children With Reduced Organic Solute Transporter-α (SLC51A) Expression. JPGN Reports 2022; 3(3): e229 doi: 10.1097/PG9.0000000000000229
|
9 |
Akihiko Kimura, Jun Mori, Anh-Hoa Nguyen Pham, Kim-Oanh Bui Thi, Hajime Takei, Tsuyoshi Murai, Hisamitsu Hayashi, Hiroshi Nittono. Healthy Patients With AKR1D1 Mutation Not Requiring Primary Bile Acid Therapy: A Case Series. JPGN Reports 2023; 4(4): e372 doi: 10.1097/PG9.0000000000000372
|
10 |
Mitsuyoshi Suzuki, Hajime Takei, Hiromi Suzuki, Jun Mori, Satoru Sugimoto, Tatsuki Mizuochi, Akira Ohtake, Hisamitsu Hayashi, Akihiko Kimura, Hiroshi Nittono. Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders. Molecular Genetics and Metabolism Reports 2024; 41: 101166 doi: 10.1016/j.ymgmr.2024.101166
|